These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24011865)

  • 21. Heart failure and B-type natriuretic protein.
    Hoyne J
    Clin Lab Sci; 2009; 22(4):233-9. PubMed ID: 19967919
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study.
    Carlsen CM; Bay M; Kirk V; Gøtze JP; Køber L; Nielsen OW
    Eur J Heart Fail; 2012 Mar; 14(3):240-7. PubMed ID: 22315457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Brain natriuretic peptide: diagnosis and treatment].
    Domínguez Rodríguez A; Amaro León MI; Burillo Putze G
    Med Clin (Barc); 2003 Mar; 120(10):387-8. PubMed ID: 12681104
    [No Abstract]   [Full Text] [Related]  

  • 24. New B-type natriuretic peptide test (pro-BNP) for heart failure.
    Cardiovasc J S Afr; 2002; 13(5):272. PubMed ID: 12557877
    [No Abstract]   [Full Text] [Related]  

  • 25. Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study.
    Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Sportouch-Dukhan C; Drouet E; Daubert JC; Linde C;
    Arch Cardiovasc Dis; 2014 Feb; 107(2):112-21. PubMed ID: 24388161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-type natriuretic peptides: applications for heart failure management in 2005.
    Troughton RW; Richards M
    Intern Med J; 2005 Jul; 35(7):377-9. PubMed ID: 15958104
    [No Abstract]   [Full Text] [Related]  

  • 27. How big a problem is heart failure with a normal ejection fraction?
    Rutten FH; Clark AL; Hoes AW
    BMJ; 2016 Apr; 353():i1706. PubMed ID: 27091176
    [No Abstract]   [Full Text] [Related]  

  • 28. [Natriuretic peptides in heart failure: improving diagnosis and management of the syndrome].
    Salomone OA OA
    Rev Esp Cardiol; 2002 Jan; 55(1):4-6. PubMed ID: 11784517
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
    Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
    Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Natriuretic peptides in heart failure].
    Hildebrandt P
    Tidsskr Nor Laegeforen; 2003 Aug; 123(15):2009. PubMed ID: 12934116
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry.
    Hsich EM; Grau-Sepulveda MV; Hernandez AF; Eapen ZJ; Xian Y; Schwamm LH; Bhatt DL; Fonarow GC
    Am Heart J; 2013 Dec; 166(6):1063-1071.e3. PubMed ID: 24268222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natriuretic peptide tests in suspected acute heart failure.
    Rutten FH; Hoes AW
    BMJ; 2015 Mar; 350():h1164. PubMed ID: 25740798
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnostic significance of serum galectin-3 levels in heart failure with preserved ejection fraction.
    Polat V; Bozcali E; Uygun T; Opan S; Karakaya O
    Acta Cardiol; 2016 Apr; 71(2):191-7. PubMed ID: 27090041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of tissue Doppler echocardiography in the emergency diagnosis of decompensated heart failure with preserved left ventricular systolic function: comparison with B-type natriuretic peptide measurement.
    Arques S; Roux E; Sbragia P; Ambrosi P; Taieb L; Pieri B; Gelisse R; Luccioni R
    Echocardiography; 2005 Sep; 22(8):657-64. PubMed ID: 16174119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BNP for clinical monitoring of heart failure.
    Troughton RW; Richards AM
    Heart Fail Clin; 2006 Jul; 2(3):333-43. PubMed ID: 17386902
    [No Abstract]   [Full Text] [Related]  

  • 36. [Plasma brain natriuretic peptide levels in the diagnostic and prognostic assessment of patients with heart failure. Pros].
    Metra M; Nodari S; Pedrinazzi C; Rocca P; Manerba A; Vizzardi E; Danesi R; Dei Cas L
    Ital Heart J; 2003 Dec; 4 Suppl 8():59S-67S. PubMed ID: 15005534
    [No Abstract]   [Full Text] [Related]  

  • 37. Surfing the biomarker tsunami at JACC: heart failure.
    Januzzi JL; Felker GM
    JACC Heart Fail; 2013 Jun; 1(3):213-5. PubMed ID: 24621872
    [No Abstract]   [Full Text] [Related]  

  • 38. Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care.
    Verdú JM; Comín-Colet J; Domingo M; Lupón J; Gómez M; Molina L; Casacuberta JM; Muñoz MA; Mena A; Bruguera-Cortada J
    Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):613-9. PubMed ID: 22541282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE).
    Komajda M; Carson PE; Hetzel S; McKelvie R; McMurray J; Ptaszynska A; Zile MR; Demets D; Massie BM
    Circ Heart Fail; 2011 Jan; 4(1):27-35. PubMed ID: 21068341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redefining heart failure.
    Thomas MD; Fox KF; Coats AJ
    Int J Cardiol; 2006 Sep; 112(2):139-41. PubMed ID: 16581144
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.